If identifying with a particular diet makes you feel more enthusiastic and motivated, that alone can be a worthwhile reason to follow it
Immunol Rev 260:820 Van Der Flier LG, Clevers H (2009) Stem cells, self-renewal, and differentiation in the intestinal epithelium
Ozempic was approved by Health Canada in 2018 specifically as a medication for people with type 2 diabetes
Europe: Bremelanotide is not yet approved by the European Medicines Agency (EMA) for any indication
How Wegovy Compares to Other GLP-1 Options in Michigan | Medication | Active ingredient | Monthly list price (2026) | Indication | |---|---|---|---| | Wegovy 2.4 mg | Semaglutide | $1,349 | Chronic weight management | | Ozempic 2 mg | Semaglutide | $935 | Type 2 diabetes (off-label for weight) | | Mounjaro 15 mg | Tirzepatide | $1,023 | Type 2 diabetes (off-label for weight) | | Zepbound 15 mg | Tirzepatide | $1,059 | Chronic weight management | | Saxenda | Liraglutide 3 mg | $1,415 | Chronic weight management | Ozempic and Mounjaro are approved for type 2 diabetes, not chronic weight management
#raregula #allulosemalaysia #malaysiahealth #malaysiamadani #waronsugar #smartsweetness #sweetnesswithoutthespike To view or add a comment, sign in 1,635 followers